Scancell Holdings PLC (SCLP)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

16.00p

Buy

17.50p

arrow-up0.35p (+2.13%)

Prices updated at 23 Aug 2024, 16:11 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.
FTSE All-Share
arrow-up0.47%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
16.40
triangle-d
arrow-up
0.10 (+0.61%)
triangle-d
Today open
16.50
triangle-d
arrow-up
0.25 (+1.52%)
triangle-d
Today, 16:11:49 BST
16.75
triangle-d
17.25p - 16.00p
19.75p - 7.59p
-
155.71m
-
30,000
505,560
-
688,871.99
1.54
819.22m
GB00B63D3314
-0.01
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.